English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Eli Lilly And Company
Patient Daily
| May 25, 2023
Lilly ESG Report Highlights Progress Towards Sustainability Goals
Patient Daily
| May 24, 2023
Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
Patient Daily
| May 22, 2023
Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Patient Daily
| May 9, 2023
Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
Patient Daily
| May 9, 2023
Lilly Declares Second-Quarter 2023 Dividend
Patient Daily
| May 9, 2023
Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
Patient Daily
| Apr 26, 2023
Lilly to Divest BAQSIMI to Amphastar
Patient Daily
| Apr 26, 2023
Lilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities
Trending
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
+
Pharmaceuticals
Patient Daily
| Jul 21, 2025
Executive director of COA on 340B abuse: ‘Imagine using cancer patients as a source of revenue’
Patient Daily
| Jul 24, 2025
Long School of Medicine is largest physician trainer in South Texas
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Genome assembly marks milestone in soft tick research
1
2
3
»
Last »